Yüklüyor......

Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness

Type 2 diabetes (T2D) is a highly prevalent disorder that affects millions of people worldwide. The hallmark of T2D is hyperglycemia and, while many treatment modalities exist, achieving and maintaining glycemic control can be challenging. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Chronic Dis
Asıl Yazarlar: Anderson, Sarah L., Trujillo, Jennifer M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707429/
https://ncbi.nlm.nih.gov/pubmed/26770666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315609312
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!